Call Options Transactions Made in Q4 2022 in Blueprint Medicines Corp (BPMC)
This table provides information about the institutional ownership of Blueprint Medicines Corp (BPMC) during Q4 2022. The information is specifically focused on institutions that hold call options of Blueprint Medicines Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
CALL |
36KNew |
$1.48M - $2.39M
|
36K
$3.15M
|
|
|
Feb 14, 2023
Q4 2022
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
CALL |
3.9KNew |
$160K - $259K
|
3.9K
$341K
|
|
|
Feb 14, 2023
Q4 2022
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
3.2KNew |
$131K - $213K
|
3.2K
$280K
|
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
CALL |
-13K- 34.21% |
$534K - $864K
|
25K
$2.19M
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-45.9K- 72.63% |
$1.88M - $3.05M
|
17.3K
$1.51M
|
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-80.2K- 64.31% |
$3.29M - $5.33M
|
44.5K
$3.89M
|